Mortality associated with chronic liver disease (CLD) and metabolic syndrome (MetS) increased substantially from 1999 to 2023 ...

Patients with lean vs nonlean metabolic dysfunction-associated steatotic liver disease (MASLD) have a significantly increased ...

A quality improvement initiative in a hepatology clinic increased alcohol use disorder pharmacotherapy prescriptions from 10% ...

Semaglutide 2.4 mg produces weight-independent liver benefits among individuals with metabolic dysfunction-associated steatohepatitis.

The Food and Drug Administration (FDA) has moved to restrict the sale of unapproved ingestible fluoride prescription drug products, stating that action will be taken against any company marketing the ...

Dr George Tidmarsh, the head of the FDA's drug division, stepped down Sunday after questioning a new fast-track drug approval program.

A machine learning model using routine lab data at 3 months postdiagnosis accurately predicted mortality or liver transplant risk in autoimmune hepatitis.

Developers of biosimilars will no longer be required to conduct clinical trials to prove effectiveness for FDA approval.

Patients with different subtypes of metabolic syndrome experience varying prevalence rates of stroke and ischemic heart disease.

Higher dietary fiber intake — especially from cereals and fruits — may reduce the risk of developing gout among women.

Primary OS analysis results from STELLAR-303 showed zanzalintinib + atezolizumab improved OS vs regorafenib in metastatic colorectal cancer.

Participants who underwent sugar rationing in utero plus 1 to 2 years had a lower risk for cardiovascular disease, myocardial infarction, heart failure, atrial fibrillation, and stroke, as well as ...